跳至主要内容
临床试验/IRCT201101205652N1
IRCT201101205652N1已完成2 期

Comparison of Effect of Oral Clonidine Premedication on Blood Loss in Lumbar Spinal Posterior Fusion Surgery with that of Plasebo

Vice chancellor for research, Tehran (previous Iran) University of Medical Science0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 65 years(—)
性别
All

入选标准

  • inclusion criteria: 20-65yr old with American Society of Anesthesia (ASA) physical status of I-II candidated for posterior fusion of lumbar spine at 3 to 4 levels due to traumatic vertebral fracture
  • The exclusion criteria: significant underlying disease (hypertension, hepatic or renal disease, coagulation defects, diabetes mellitus), being under beta-blocker, calcium channel blocker, dioxin, tricyclic antidepressant, anticoagulant or clonidine treatment, drug or alcohol abuse.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Tehran (previous Iran) University of Medical Science

相似试验